Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fluorouracil (efudex) (1 trial)
mitomycin (mutamycin) (1 trial)
panitumumab (vectibix) (1 trial)
Anus Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Trials (1 total)
Trial APIs (3 total)